Literature DB >> 22488319

[Hospital costs related to streptococcal meningitis among children in São José dos Campos, São Paulo State, Brazil].

Bianca Rezende Lucarevschi1, Ana Maria de Ulhôa Escobar, Sandra Grisi.   

Abstract

Knowledge of hospital costs is highly important for public health decision-making. This study aimed to estimate direct hospital costs related to pneumococcal meningitis in children 13 years or younger in the city of São José dos Campos, São Paulo State, Brazil, from January 1999 to December 2008. Data were obtained from medical records. Hospital costs were calculated according to the mixed method for measurement of quantities of items with identified costs and value attribution to items consumed (micro-costing and gross-costing). All costs were calculated according to monetary values for November 2009 and in Brazilian currency (Real). Epi Info 3.5.1 was used for frequencies and means analysis. Forty-one cases were reported. Direct hospital costs varied from R$ 1,277.90 to R$ 19,887.56 (mean = R$ 5,666.43), or 10 to 20 times the mean cost of hospitalization for other diseases. Hospital staff labor was the highest cost, followed by medication, procedures, supplies, and lab tests.

Entities:  

Mesh:

Year:  2012        PMID: 22488319     DOI: 10.1590/s0102-311x2012000400013

Source DB:  PubMed          Journal:  Cad Saude Publica        ISSN: 0102-311X            Impact factor:   1.632


  2 in total

1.  Measurement and valuation of health providers' time for the management of childhood pneumonia in rural Malawi: an empirical study.

Authors:  Fiammetta Maria Bozzani; Matthias Arnold; Timothy Colbourn; Norman Lufesi; Bejoy Nambiar; Gibson Masache; Jolene Skordis-Worrall
Journal:  BMC Health Serv Res       Date:  2016-07-28       Impact factor: 2.655

2.  Glucose-6-phosphate dehydrogenase deficiency and the use of primaquine: top-down and bottom-up estimation of professional costs.

Authors:  Henry Maia Peixoto; Marcelo Augusto Mota Brito; Gustavo Adolfo Sierra Romero; Wuelton Marcelo Monteiro; Marcus Vinícius Guimarães de Lacerda; Maria Regina Fernandes de Oliveira
Journal:  Rev Saude Publica       Date:  2017-10-05       Impact factor: 2.106

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.